nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CHRM2—type 1 diabetes mellitus	0.517	0.745	CbGaD
Olanzapine—ALB—type 1 diabetes mellitus	0.177	0.255	CbGaD
Olanzapine—FMO3—sweat—type 1 diabetes mellitus	0.0212	0.221	CbGeAlD
Olanzapine—HTR7—umbilical artery—type 1 diabetes mellitus	0.0136	0.142	CbGeAlD
Olanzapine—HTR2A—arteriole—type 1 diabetes mellitus	0.00488	0.0507	CbGeAlD
Olanzapine—ORM1—saliva—type 1 diabetes mellitus	0.00453	0.0471	CbGeAlD
Olanzapine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00335	0.0348	CbGeAlD
Olanzapine—DRD1—nerve—type 1 diabetes mellitus	0.00302	0.0314	CbGeAlD
Olanzapine—HTR3A—nerve—type 1 diabetes mellitus	0.00291	0.0303	CbGeAlD
Olanzapine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00242	0.0251	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00209	0.0217	CbGeAlD
Olanzapine—HTR7—nerve—type 1 diabetes mellitus	0.00188	0.0196	CbGeAlD
Olanzapine—DRD2—nerve—type 1 diabetes mellitus	0.00178	0.0185	CbGeAlD
Olanzapine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00177	0.0184	CbGeAlD
Olanzapine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00151	0.0157	CbGeAlD
Olanzapine—H1F0—islet of Langerhans—type 1 diabetes mellitus	0.00148	0.0154	CbGeAlD
Olanzapine—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.00141	0.0147	CbGeAlD
Olanzapine—HRH2—cardiovascular system—type 1 diabetes mellitus	0.0013	0.0135	CbGeAlD
Olanzapine—H1F0—retina—type 1 diabetes mellitus	0.00126	0.0132	CbGeAlD
Olanzapine—H1F0—nephron tubule—type 1 diabetes mellitus	0.00119	0.0124	CbGeAlD
Olanzapine—HTR2A—nerve—type 1 diabetes mellitus	0.00118	0.0122	CbGeAlD
Olanzapine—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.00116	0.0121	CbGeAlD
Olanzapine—ADRA1B—kidney—type 1 diabetes mellitus	0.00111	0.0115	CbGeAlD
Olanzapine—H1F0—cardiovascular system—type 1 diabetes mellitus	0.00107	0.0111	CbGeAlD
Olanzapine—H1F0—kidney—type 1 diabetes mellitus	0.00105	0.0109	CbGeAlD
Olanzapine—H1F0—pancreas—type 1 diabetes mellitus	0.00104	0.0108	CbGeAlD
Olanzapine—H1F0—lymphoid tissue—type 1 diabetes mellitus	0.000899	0.00935	CbGeAlD
Olanzapine—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.000856	0.0089	CbGeAlD
Olanzapine—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000852	0.00886	CbGeAlD
Olanzapine—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.000829	0.00862	CbGeAlD
Olanzapine—HTR1D—kidney—type 1 diabetes mellitus	0.000811	0.00843	CbGeAlD
Olanzapine—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000775	0.00806	CbGeAlD
Olanzapine—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.000771	0.00802	CbGeAlD
Olanzapine—DRD2—retina—type 1 diabetes mellitus	0.000738	0.00768	CbGeAlD
Olanzapine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000691	0.00719	CbGeAlD
Olanzapine—CHRM3—kidney—type 1 diabetes mellitus	0.000679	0.00706	CbGeAlD
Olanzapine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000676	0.00703	CbGeAlD
Olanzapine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00067	0.00696	CbGeAlD
Olanzapine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.00066	0.00687	CbGeAlD
Olanzapine—HTR7—kidney—type 1 diabetes mellitus	0.000646	0.00672	CbGeAlD
Olanzapine—Loxapine—CHRM2—type 1 diabetes mellitus	0.000643	0.273	CrCbGaD
Olanzapine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000637	0.00662	CbGeAlD
Olanzapine—Quetiapine—CHRM2—type 1 diabetes mellitus	0.000628	0.266	CrCbGaD
Olanzapine—ADRA2C—kidney—type 1 diabetes mellitus	0.000594	0.00618	CbGeAlD
Olanzapine—ADRA2C—pancreas—type 1 diabetes mellitus	0.00059	0.00613	CbGeAlD
Olanzapine—Loxapine—ADRB1—type 1 diabetes mellitus	0.000549	0.232	CrCbGaD
Olanzapine—Clozapine—CHRM2—type 1 diabetes mellitus	0.00054	0.229	CrCbGaD
Olanzapine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000535	0.00557	CbGeAlD
Olanzapine—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.0005	0.0052	CbGeAlD
Olanzapine—HTR2A—retina—type 1 diabetes mellitus	0.000487	0.00506	CbGeAlD
Olanzapine—ADRA2A—pancreas—type 1 diabetes mellitus	0.000471	0.0049	CbGeAlD
Olanzapine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000412	0.00428	CbGeAlD
Olanzapine—HTR2A—kidney—type 1 diabetes mellitus	0.000403	0.00419	CbGeAlD
Olanzapine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000373	0.00388	CbGeAlD
Olanzapine—CYP3A4—kidney—type 1 diabetes mellitus	0.000373	0.00388	CbGeAlD
Olanzapine—CYP2D6—kidney—type 1 diabetes mellitus	0.000367	0.00382	CbGeAlD
Olanzapine—ABCB1—retina—type 1 diabetes mellitus	0.000319	0.00332	CbGeAlD
Olanzapine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.0003	0.00312	CbGeAlD
Olanzapine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00027	0.00281	CbGeAlD
Olanzapine—ABCB1—kidney—type 1 diabetes mellitus	0.000264	0.00275	CbGeAlD
Olanzapine—ABCB1—pancreas—type 1 diabetes mellitus	0.000262	0.00273	CbGeAlD
Olanzapine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000227	0.00236	CbGeAlD
Olanzapine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.57e-06	3.16e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.57e-06	3.16e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	6.56e-06	3.16e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.55e-06	3.15e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.55e-06	3.15e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.55e-06	3.15e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.54e-06	3.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.54e-06	3.15e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	6.54e-06	3.15e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.53e-06	3.14e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	6.52e-06	3.14e-05	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—IL6—type 1 diabetes mellitus	6.51e-06	3.13e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.5e-06	3.13e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.49e-06	3.12e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	6.42e-06	3.09e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.41e-06	3.09e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	6.4e-06	3.08e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	6.38e-06	3.07e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.37e-06	3.07e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	6.35e-06	3.05e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.34e-06	3.05e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.31e-06	3.04e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.31e-06	3.04e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.31e-06	3.04e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	6.3e-06	3.03e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.28e-06	3.02e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.27e-06	3.02e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	6.24e-06	3.01e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.22e-06	3e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	6.21e-06	2.99e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.18e-06	2.98e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	6.16e-06	2.97e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	6.16e-06	2.96e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.14e-06	2.95e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.11e-06	2.94e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.09e-06	2.93e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.07e-06	2.92e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	6.06e-06	2.92e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	6.05e-06	2.91e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.04e-06	2.91e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.02e-06	2.9e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	6.01e-06	2.89e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.01e-06	2.89e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	6.01e-06	2.89e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	6e-06	2.89e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	6e-06	2.89e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.98e-06	2.88e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.98e-06	2.88e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	5.97e-06	2.88e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.96e-06	2.87e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.96e-06	2.87e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.96e-06	2.87e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	5.95e-06	2.86e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	5.94e-06	2.86e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.92e-06	2.85e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	5.89e-06	2.84e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.89e-06	2.83e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.87e-06	2.83e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	5.87e-06	2.82e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.86e-06	2.82e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.83e-06	2.81e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	5.76e-06	2.77e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.75e-06	2.77e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.72e-06	2.75e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.68e-06	2.73e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.67e-06	2.73e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.67e-06	2.73e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—IL6—type 1 diabetes mellitus	5.67e-06	2.73e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	5.67e-06	2.73e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	5.65e-06	2.72e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	5.65e-06	2.72e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.64e-06	2.72e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	5.63e-06	2.71e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	5.62e-06	2.7e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.6e-06	2.7e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	5.59e-06	2.69e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.58e-06	2.69e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.57e-06	2.68e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.57e-06	2.68e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.56e-06	2.68e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	5.56e-06	2.68e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.55e-06	2.67e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.54e-06	2.67e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.54e-06	2.67e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.54e-06	2.67e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.5e-06	2.65e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.48e-06	2.64e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.48e-06	2.64e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.47e-06	2.63e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.45e-06	2.63e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.45e-06	2.63e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.45e-06	2.62e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.44e-06	2.62e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.43e-06	2.62e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.42e-06	2.61e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.41e-06	2.6e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	5.41e-06	2.6e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.38e-06	2.59e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.38e-06	2.59e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.37e-06	2.58e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.35e-06	2.58e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.34e-06	2.57e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.3e-06	2.55e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.23e-06	2.52e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	5.15e-06	2.48e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.14e-06	2.48e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	5.13e-06	2.47e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.06e-06	2.44e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.06e-06	2.44e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.06e-06	2.43e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.05e-06	2.43e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.05e-06	2.43e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.05e-06	2.43e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.05e-06	2.43e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.04e-06	2.42e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.03e-06	2.42e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.03e-06	2.42e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.02e-06	2.42e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.02e-06	2.42e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	5.01e-06	2.41e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.01e-06	2.41e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	5e-06	2.41e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.99e-06	2.4e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.97e-06	2.39e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.97e-06	2.39e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.96e-06	2.39e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.96e-06	2.39e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.96e-06	2.39e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.94e-06	2.38e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.93e-06	2.37e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.89e-06	2.36e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.88e-06	2.35e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.88e-06	2.35e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.87e-06	2.35e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—INS—type 1 diabetes mellitus	4.86e-06	2.34e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.86e-06	2.34e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.86e-06	2.34e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.85e-06	2.34e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.85e-06	2.33e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.83e-06	2.32e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.82e-06	2.32e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.77e-06	2.3e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.75e-06	2.29e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.72e-06	2.27e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.72e-06	2.27e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.71e-06	2.27e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.69e-06	2.26e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.67e-06	2.25e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.65e-06	2.24e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.64e-06	2.24e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.62e-06	2.22e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.6e-06	2.22e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.6e-06	2.21e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.55e-06	2.19e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.52e-06	2.18e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	4.37e-06	2.1e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.34e-06	2.09e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.29e-06	2.06e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.28e-06	2.06e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.28e-06	2.06e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—NOS3—type 1 diabetes mellitus	4.27e-06	2.05e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	4.26e-06	2.05e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.26e-06	2.05e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.25e-06	2.05e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.22e-06	2.03e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.21e-06	2.03e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.21e-06	2.03e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.2e-06	2.02e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.2e-06	2.02e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.19e-06	2.02e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.19e-06	2.02e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.18e-06	2.01e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.18e-06	2.01e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.18e-06	2.01e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.17e-06	2.01e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.15e-06	2e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.14e-06	1.99e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.13e-06	1.99e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.13e-06	1.99e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.12e-06	1.99e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.11e-06	1.98e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.1e-06	1.98e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.1e-06	1.98e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.08e-06	1.96e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	4.02e-06	1.93e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	4e-06	1.93e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.98e-06	1.92e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.97e-06	1.91e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.96e-06	1.9e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.91e-06	1.88e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.91e-06	1.88e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	3.87e-06	1.86e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	3.87e-06	1.86e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.86e-06	1.86e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	3.84e-06	1.85e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.84e-06	1.85e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.83e-06	1.84e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.83e-06	1.84e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.81e-06	1.84e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.76e-06	1.81e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.74e-06	1.8e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.73e-06	1.8e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.71e-06	1.79e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.7e-06	1.78e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.68e-06	1.77e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.65e-06	1.76e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	3.65e-06	1.76e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.61e-06	1.74e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.6e-06	1.73e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.55e-06	1.71e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.54e-06	1.71e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.54e-06	1.7e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.53e-06	1.7e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.52e-06	1.7e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.52e-06	1.7e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.51e-06	1.69e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	3.5e-06	1.68e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	3.49e-06	1.68e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.48e-06	1.68e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.47e-06	1.67e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.4e-06	1.64e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.33e-06	1.6e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.29e-06	1.58e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.27e-06	1.58e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.22e-06	1.55e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.22e-06	1.55e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.21e-06	1.55e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.2e-06	1.54e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.19e-06	1.54e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.16e-06	1.52e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.15e-06	1.52e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	3.12e-06	1.5e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.98e-06	1.44e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.97e-06	1.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.93e-06	1.41e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.87e-06	1.38e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.85e-06	1.37e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.77e-06	1.33e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.73e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.63e-06	1.26e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.52e-06	1.21e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.48e-06	1.19e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.47e-06	1.19e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.46e-06	1.19e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.45e-06	1.18e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.43e-06	1.17e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.42e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.41e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.3e-06	1.11e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.25e-06	1.08e-05	CbGpPWpGaD
